JoVE Logo
Faculty Resource Center

Sign In

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

DOI :

10.3791/54798-v

January 18th, 2017

January 18th, 2017

12,055 Views

1Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, 2Medicinal Chemistry and Pharmacognosy, College of Medicine, University of Illinois at Chicago, 3College of Pharmacy, University of Illinois at Chicago

This procedure will demonstrate how we synthesized and characterized the anti-NFκB and anti-cancer stem cell activity of an aspirin-fumarate prodrug.

Tags

Synthesis

-- Views

Related Videos

article

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

article

Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles

article

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal

article

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

article

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

article

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

article

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

article

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells

article

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

article

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved